Souders Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $649K | Buy |
|
|||||
|
2025
Q2 | $443K | Sell |
|
|||||
|
2025
Q1 | $484K | Sell |
|
|||||
|
2024
Q4 | $645K | Sell |
|
|||||
|
2024
Q3 | $922K | Sell |
|
|||||
|
2024
Q2 | $853K | Buy |
|
|||||
|
2024
Q1 | $519K | Buy |
|
|||||
|
2023
Q4 | $564K | Buy |
|
|||||
|
2023
Q3 | $477K | Buy |
|
|||||
|
2023
Q2 | $504K | Buy |
|
|||||
|
2023
Q1 | $448K | Buy |
|
|||||
|
2022
Q4 | $518K | Buy |
|
|||||
|
2022
Q3 | $334K | Buy |
|